Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse
Exelixis
Exelixis
Day One Biopharmaceuticals, Inc.
Alaunos Therapeutics
BioMimetix JV, LLC
Bayer
BeiGene
Istari Oncology, Inc.
Candel Therapeutics, Inc.
Novartis
Sumitomo Pharma America, Inc.
TVAX Biomedical
TVAX Biomedical
Karyopharm Therapeutics Inc
Pfizer
Merck Sharp & Dohme LLC
Novartis
Merck Sharp & Dohme LLC
Isarna Therapeutics GmbH
Celtic Pharma Development Services
INSYS Therapeutics Inc
Celtic Pharma Development Services